Update from ASCO GU 2018 (1 of 3)
Update from ASCO GU 2018 (1 of 3)
Prof. Evan Yu
GU CONNECT has summarised the highlights of the recent ASCO GU 2018 meeting for you.Prof. Evan Yu
Medical Oncologist
University of Washington and Seattle Cancer Care Alliance
United States (US)
Prof. Evan Yu has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2018
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Non-metastatic castration-resistant prostate cancer (M0 CRPC) by Prof. Evan Y. Yu, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, USA
GU CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.